AI assistant
Sending…
Traws Pharma, Inc. — Director's Dealing 2021
Jun 18, 2021
35199_dirs_2021-06-17_b1c43c71-4093-4d0f-afd7-65ef2d6ecdb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2021-06-14
Reporting Person: Gelder Mark S. MD (Chief Medical Officer)
More from Traws Pharma, Inc.
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Share Issue/Capital Change
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 8